Abstract
AIM: To assess the value of the intensive histological work up of axillary sentinel lymph nodes (SLN) to demonstrate regional metastatic disease. METHODS: From a series of 58 successful lymphatic mapping procedures, 78 SLN were analysed by serial sections (mean of 49 levels/SLN) and by immunostaining to cytokeratin and epithelial membrane antigen, and the results compared with those obtained by assessing the central cross section. RESULTS: The central cross section would have failed to detect metastases in eight of 26 lymph nodes (31%) in patients with breast cancer metastasising to the SLN only. This would have led to a false negative node status in six of 21 patients (29%). Two micrometastases were detected with the aid of immunostains. CONCLUSIONS: The results suggest the need to examine SLN at multiple levels and to use immunohistochemistry in negative cases. Serial sections are also useful in the case of micrometastases, as some of these may convert to macrometastases at deeper levels. Multiple level investigation of SLN and immunohistochemistry in the event of the negativity of standard stains would result in improved staging and an increase in the proportion of node positive disease detected.
Full text
PDF


Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Albertini J. J., Lyman G. H., Cox C., Yeatman T., Balducci L., Ku N., Shivers S., Berman C., Wells K., Rapaport D. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996 Dec 11;276(22):1818–1822. [PubMed] [Google Scholar]
- Barnwell J. M., Arredondo M. A., Kollmorgen D., Gibbs J. F., Lamonica D., Carson W., Zhang P., Winston J., Edge S. B. Sentinel node biopsy in breast cancer. Ann Surg Oncol. 1998 Mar;5(2):126–130. doi: 10.1007/BF02303845. [DOI] [PubMed] [Google Scholar]
- Borgstein P. J., Pijpers R., Comans E. F., van Diest P. J., Boom R. P., Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg. 1998 Mar;186(3):275–283. doi: 10.1016/s1072-7515(98)00011-8. [DOI] [PubMed] [Google Scholar]
- Bostick P. J., Huynh K. T., Sarantou T., Turner R. R., Qi K., Giuliano A. E., Hoon D. S. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer. 1998 Dec 18;79(6):645–651. doi: 10.1002/(sici)1097-0215(19981218)79:6<645::aid-ijc16>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
- Cabanas R. M. An approach for the treatment of penile carcinoma. Cancer. 1977 Feb;39(2):456–466. doi: 10.1002/1097-0142(197702)39:2<456::aid-cncr2820390214>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
- Dale P. S., Williams J. T., 4th Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma. Am Surg. 1998 Jan;64(1):28–32. [PubMed] [Google Scholar]
- Feinstein A. R., Sosin D. M., Wells C. K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985 Jun 20;312(25):1604–1608. doi: 10.1056/NEJM198506203122504. [DOI] [PubMed] [Google Scholar]
- Flett M. M., Going J. J., Stanton P. D., Cooke T. G. Sentinel node localization in patients with breast cancer. Br J Surg. 1998 Jul;85(7):991–993. doi: 10.1046/j.1365-2168.1998.00746.x. [DOI] [PubMed] [Google Scholar]
- Giuliano A. E., Jones R. C., Brennan M., Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol. 1997 Jun;15(6):2345–2350. doi: 10.1200/JCO.1997.15.6.2345. [DOI] [PubMed] [Google Scholar]
- Giuliano A. E., Kirgan D. M., Guenther J. M., Morton D. L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994 Sep;220(3):391–401. doi: 10.1097/00000658-199409000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guenther J. M., Krishnamoorthy M., Tan L. R. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am. 1997 Nov-Dec;3(6):336–340. [PubMed] [Google Scholar]
- Jannink I., Fan M., Nagy S., Rayudu G., Dowlatshahi K. Serial sectioning of sentinel nodes in patients with breast cancer: a pilot study. Ann Surg Oncol. 1998 Jun;5(4):310–314. doi: 10.1007/BF02303493. [DOI] [PubMed] [Google Scholar]
- Kelemen P. R., Van Herle A. J., Giuliano A. E. Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch Surg. 1998 Mar;133(3):288–292. doi: 10.1001/archsurg.133.3.288. [DOI] [PubMed] [Google Scholar]
- Koller M., Barsuk D., Zippel D., Engelberg S., Ben-Ari G., Papa M. Z. Sentinel lymph node involvement--a predictor for axillary node status with breast cancer--has the time come? Eur J Surg Oncol. 1998 Jun;24(3):166–168. doi: 10.1016/s0748-7983(98)92827-x. [DOI] [PubMed] [Google Scholar]
- Krag D. N., Weaver D. L., Alex J. C., Fairbank J. T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993 Dec;2(6):335–340. doi: 10.1016/0960-7404(93)90064-6. [DOI] [PubMed] [Google Scholar]
- Miner T. J., Shriver C. D., Jaques D. P., Maniscalco-Theberge M. E., Krag D. N. Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer. Ann Surg Oncol. 1998 Jun;5(4):315–321. doi: 10.1007/BF02303494. [DOI] [PubMed] [Google Scholar]
- Morton D. L., Wen D. R., Wong J. H., Economou J. S., Cagle L. A., Storm F. K., Foshag L. J., Cochran A. J. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992 Apr;127(4):392–399. doi: 10.1001/archsurg.1992.01420040034005. [DOI] [PubMed] [Google Scholar]
- O'Hea B. J., Hill A. D., El-Shirbiny A. M., Yeh S. D., Rosen P. P., Coit D. G., Borgen P. I., Cody H. S., 3rd Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg. 1998 Apr;186(4):423–427. doi: 10.1016/s1072-7515(98)00060-x. [DOI] [PubMed] [Google Scholar]
- PICKREN J. W. Significance of occult metastases. A study of breast cancer. Cancer. 1961 Nov-Dec;14:1266–1271. doi: 10.1002/1097-0142(196111/12)14:6<1266::aid-cncr2820140617>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
- Pijpers R., Meijer S., Hoekstra O. S., Collet G. J., Comans E. F., Boom R. P., van Diest P. J., Teule G. J. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med. 1997 Mar;38(3):366–368. [PubMed] [Google Scholar]
- Reuhl T., Kaisers H., Markwardt J., Haensch W., Hohenberger P., Schlag P. M. Axillaausräumung bei klinisch nodal-negativem Mammakarzinom. Kann die Indikation durch "sentinel node"-Nachweis individualisiert werden? Dtsch Med Wochenschr. 1998 May 8;123(19):583–587. doi: 10.1055/s-2007-1024023. [DOI] [PubMed] [Google Scholar]
- Roumen R. M., Valkenburg J. G., Geuskens L. M. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol. 1997 Dec;23(6):495–502. doi: 10.1016/s0748-7983(97)92885-7. [DOI] [PubMed] [Google Scholar]
- Turner R. R., Ollila D. W., Krasne D. L., Giuliano A. E. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg. 1997 Sep;226(3):271–278. doi: 10.1097/00000658-199709000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Veronesi U., Paganelli G., Galimberti V., Viale G., Zurrida S., Bedoni M., Costa A., de Cicco C., Geraghty J. G., Luini A. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997 Jun 28;349(9069):1864–1867. doi: 10.1016/S0140-6736(97)01004-0. [DOI] [PubMed] [Google Scholar]
- Zhang P. J., Reisner R. M., Nangia R., Edge S. B., Brooks J. J. Effectiveness of multiple-level sectioning in detecting axillary nodal micrometastasis in breast cancer: a retrospective study with immunohistochemical analysis. Arch Pathol Lab Med. 1998 Aug;122(8):687–690. [PubMed] [Google Scholar]